EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec

Laura Retson, Nishant Tiwari, Jennifer Vaughn, Saunder Bernes, P David Adelson, Keith Mansfield, Silvana Libertini, Brent Kuzmiski, Iulian Alecu, Richard Gabriel, Ross Mangum

Molecular Therapy · 2023

DOI: 10.1016/j.ymthe.2023.08.013 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Molecular Therapy, 2023. Verfasst von Laura Retson und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA. Hauptthemen laut MEDLINE: Genetic Therapy, Genetic Vectors. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Novartis Gene Therapies.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spinal muscular atrophy is an autosomal recessive disease resulting in motor neuron degeneration and progressive life-limiting motor deficits when untreated. Onasemnogene abeparvovec is an adeno-associated virus serotype 9-based gene therapy that improves survival, motor function, and motor milestone achievement in symptomatic and presymptomatic patients. Although the adeno-associated virus genome is maintained as an episome, theoretical risk of tumorigenicity persists should genomic insertion occur. We present the case of a 16-month-old male with spinal muscular atrophy who was diagnosed with an epithelioid neoplasm of the spinal cord approximately 14 months after receiving onasemnogene abeparvovec. In situ hybridization analysis detected an onasemnogene abeparvovec nucleic acid signal broadly distributed in many but not all tumor cells. Integration site analysis on patient formalin-fixed, paraffin-embedded tumor samples failed to detect high-confidence integration sites of onasemnogene abeparvovec. The finding was considered inconclusive because of limited remaining tissue/DNA input. The improved life expectancy resulting from innovative spinal muscular atrophy therapies, including onasemnogene abeparvovec, has created an opportunity to analyze the long-term adverse events and durability of these therapies as well as identify potential disease associations that were previously unrecognized because of the premature death of these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyGenetic VectorsHumansMaleInfantMuscular Atrophy, SpinalBiological ProductsDependovirusSpinal Cord NeoplasmsRecombinant Fusion Proteins

Stichwörter der Autor:innen

epithelioid neoplasmin situ hybridizationonasemnogene abeparvovecspinal muscular atrophyspinal tumor, gene therapy

Substanzen

ZolgensmaBiological ProductsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Pathology & Laboratory Medicine, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Department of Radiology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Department of Neurology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA.
  • Department of Neurosurgery, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA.
  • Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA.

Förderung

  • Novartis Gene Therapies

Zitieren

APA

Retson, L., Tiwari, N., Vaughn, J., Bernes, S., Adelson, P. D., Mansfield, K., Libertini, S., Kuzmiski, B., Alecu, I., Gabriel, R., & Mangum, R. (2023). Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2023.08.013

Vancouver

Retson L, Tiwari N, Vaughn J, Bernes S, Adelson PD, Mansfield K, et al. Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec. Molecular Therapy. 2023. doi:10.1016/j.ymthe.2023.08.013

BibTeX
@article{Retson2023,
  author = {Retson, Laura and Tiwari, Nishant and Vaughn, Jennifer and Bernes, Saunder and Adelson, P David and Mansfield, Keith and Libertini, Silvana and Kuzmiski, Brent and Alecu, Iulian and Gabriel, Richard and Mangum, Ross},
  title = {Epithelioid neoplasm of the spinal cord in a child with spinal muscular atrophy treated with onasemnogene abeparvovec},
  journal = {Molecular Therapy},
  year = {2023},
  doi = {10.1016/j.ymthe.2023.08.013}
}
Kostenlos starten →